A judge has hit property manager Meriton with a $3 million penalty after finding the company misled consumers by manipulating negative TripAdvisor reviews, but the fine was well below the $20 million sought by the consumer watchdog.
Lawyers for two competing class actions against the Commonwealth Bank of Australia over breaches of anti-money laundering laws say the cases can happily co-exist, but whether the court will agree may well depend on the outcome of a closely-watched appeal in a separate battle over multiple proceedings.
Macquarie Bank is facing a fourth lawsuit by a group of former financial advisers alleging it breached the Fair Work Act by denying them regular wages.
US tyre company Goodyear wants to challenge a ruling in a long-running dispute with UK-based rival Dunlop over coveted trade marks for ‘Dunlop’ and ‘Flying D’.
Aristocrat Technologies is pushing on with its bid for four innovation gaming patents, after a delegate for IP Australia revoked the patents because they amounted to nothing more than ‘games and game rules’.
The applicants in a class action against Radio Rentals alleging its rental practices violate responsible lending laws say the company is dragging its feet on discovery, after the company accused the applicants’ lawyers of using discovery to delay the case.
A judge has found an arbitration proceeding between Eastern Goldfields Ltd and GR Engineering Services over a $12.5 million gold mine contract can proceed despite the involvement of Squire Patton Boggs and another party in the dispute.
A judge on Friday will hear arguments in a bid by BHP Billiton to halt a class action over the mining giant’s Brazilian mine disaster, a sweeping case filed on behalf of investors who held the company’s shares in Australia, the UK or South Africa.
The litigation funder underwriting a class action against Myer will have to fork over another $950,000 in security ahead of what will be a rare shareholder trial starting next Wednesday, a court has ruled.
The first day of a liability hearing in a consumer case over GlaxoSmithKline’s marketing for its popular Voltaren products has seen an ACCC witness deflect accusations the regulator was vague about its misleading packaging concerns, placing the blame squarely on the pharmaceutical giant.